FDA Alerts
Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictions
שירי ברק
10:56
סגור לתגובות על Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictions
FDA has determined
Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding
שירי ברק
10:22
סגור לתגובות על Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding
FDA has analyzed recent data that indicate an
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
שירי ברק
13:09
סגור לתגובות על Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
FDA has required the drug labels and Medication Guides for all fluoroquinolone
FDA Warns of Fatal Skin Reactions with Acetaminophen
שירי ברק
15:54
סגור לתגובות על FDA Warns of Fatal Skin Reactions with Acetaminophen
SILVER SPRING, Md.